Black people with cancer more likely to experience heart damage with chemotherapy, study results show Canadian researchers said they were surprised by their results, which could suggest structural racism within healthcare.…
Thousands of NHS patients with prostate or breast cancer eligible for new targeted treatment NHS England says around 800 people in England could be eligible for olaparib treatment each year.…
Recent antibiotic reduces cancer survival after immune checkpoint inhibitors by 12%, study results show Results from a Canadian cohort study suggest that antibiotic therapy may reduce the effectiveness of immune checkpoint inhibitor therapy.…
Community pharmacies to start directly referring patients for cancer screening from January 2023 Exclusive: The first phase of the pilot is planned to begin this month, with further pharmacies to start referring patients in March/April 2023.…
Research, CPD and Learning: 2022 in review Celebrating the highlights from 2022 and a look ahead to 2023.…
Cancer vaccine combined with monoclonal antibody cuts risk of death or recurrence of melanoma by almost 50%, show phase II trial data Experts say the data are exciting, but warn larger trials are needed in other cancer types.…
Monoclonal antibodies for the treatment of multiple myeloma An overview of the development and use of monoclonal antibodies in the treatment of patients with multiple myeloma.…
Don’t dismiss fears over switching generics, take it from two cancer ‘thrivers’ Ruth Edwards and Avril Chester share their experience of the impact medicines shortages can have on people who rely on long-term medicines after cancer treatment.…
Compassionate medicine schemes help patients with cancer live better and for longer — why are they not more widely used? Use of unlicensed or off-label medicines for patients with cancer can extend survival or improve quality of life, but access remains patchy.…
The role of circulating tumour DNA in guiding cancer treatment and future applications An overview of current and future applications of circulating tumour DNA in common solid tumours and the implications on treatment.…